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Stoma recurrence after total laryngectomy is one of the 
most severe developments of squamous cell carcinoma of 
the larynx. Risk factors most strongly implicated in stoma 
recurrence have been subglottic invasion by the laryngeal 
tumor and tracheotomy prior to laryngectomy. Aim: Study 
the clinical findings of patients who underwent total 
laryngectomy and evaluate the probable risk factors to the 
development of stoma recurrence. Study design: Descriptive 
and retrospective study Materials and methods: We studied 
data from 47 patients who underwent total laryngectomy for 
the treatment of laryngeal cancer between 1995 and 2004 
and evaluated recurrences and risk factors. Results: Stoma 
recurrence developed in 10.6 per cent of them(5 cases). There 
was no significant correlation between stoma recurrence 
and subglottic invasion or prior tracheotomy. Conclusion: 
Stoma recurrence still is one of the most lethal developments 
associated to laryngeal cancer. In the present study it was not 
possible to identify factors related to this recurrence. Further 
studies with a larger sample and a longer follow-up period 
are necessary to better understand this condition. 
Keywords: stoma recurrence.
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INTRODUCTION
Tumor recurrence in the ultimate stomal area after 
total laryngectomy is one of the most severe developments 
of the larynx epidermoid carcinoma treated surgically.
Recurrences in the tracheostoma area started to be 
better studied after the study by Keim et al.1 in 1965. These 
authors defined it as diffuse neoplastic infiltrations in the 
area where the trachea stump joins the skin.
According to numerous studies, recurrence inciden-
ce in the tracheostoma area after total laryngectomy varies 
from 1.7% to 25% of laryngectomized patients. Nonethe-
less, there is great difficulty in knowing the real value of 
such recurrence rates, since many papers include them in 
the local recurrence group2,3.
Another significant factor that may cause difficulties 
in analyzing recurrence incidence in the tracheostoma area 
is the number of synonyms used to describe such patho-
logy, such as: tracheal metastasis, peritracheal recurrence, 
tracheal recurrence, paratracheostomal tumor, tracheosto-
mal metastasis, second primary tumor in the trachea3.
Most relapses in the tracheostoma area are diag-
nosed in the first year after total laryngectomy and its 
pathogeny is still not clearly defined1,4-7.
Tumor site and disease staging, infraglottic inva-
sion, previous tracheostomy, insufficient surgical margins 
after total laryngectomy, thyroid invasion by the laryngeal 
tumor, tumoral implants during surgery and paratracheal 
lymphnode metastasis are the most mentioned correlated 
factors in the literature1-26. There is no unanimous opinion 
as to the importance of these factors in tumor recurrence 
in the tracheostoma area. 
The different treatment modalities for these recur-
rences, that include surgery, radio and chemotherapy, have 
not been satisfactory to control the disease, and therefore, 
a special attention has been given to the prevention of 
such pathology2,8-10. Many methods have been proposed 
to prevent recurrence in the tracheostoma area, such as: 
lower trachea section allowing for a broader surgical mar-
gin, dissection of lymphnodes located in the paratracheal 
chains, emergency laryngectomies in patients that required 
tracheostomy prior to their laryngectomy, postoperative 
radiotherapy including the tracheostoma and the upper 
mediastinum1,3,7,11.
Historically, recurrences in the tracheostoma area 
are considered very difficult to treat and are associated to 
little likelihood of survival10,12-15.
The goal of the present study is to investigate the 
cases of patients in our institution who suffered laryngec-
tomy between the years of 1995 and 2004, and analyze 
the cases in which there was tumor recurrence in the tra-
cheostoma area by means of the clinical findings in these 
patients, trying to identify some risk factors in the causation 
of such pathology and what could prevent it.
MATERIALS AND METHODS
This study is based on 47 patients diagnosed with 
larynx epidermoid carcinomas, who underwent total la-
ryngectomy, from February of 1995 to January of 2004. All 
the patients included in this study did not undergo radio 
or chemotherapy prior to surgery.
As far as gender is concerned, males predominated 
(44 cases), when compared to females (3 cases), bearing 
a 14,6:1 ratio.
Minimum age was of 42 years and maximum age 
was 86 years. Average age was 63.3 years and the median 
was 61 years.
The surgical approach was total laryngectomy, 
including the resection of the tracheostomy area in those 
patients who had been tracheostomized prior to surgery, 
either with or without radical or selective uni or bilateral 
neck clearance. Indication for postoperative radiotherapy 
was determined for each patient after the results from the 
pathology study, and it was indicated in the cases of com-
promised surgical margins or the presence of histologically 
metastatic neck lymphnodes.
The lesions were classified according to the TNM-
UICC classification method. In order to frame the cases in 
specific groups, we considered the whole set of data from 
the nasofibroscopy exam, direct and indirect laryngoscopy, 
neck palpation, neck CT scan and chest X-rays.
Histopathologic diagnosis was carried out by means 
of biopsies that were, most of them, done under direct 
laryngoscopy and general anesthesia. In cases of dyspneic 
patients at the time of clinical diagnosis, they were submit-
ted to emergency tracheostomy under sedation and local 
anesthesia in the operating theater and, later on, direct 
laryngoscopy under general anesthesia. 
In order to carry out the statistical analysis among 
the different qualitative variables from the 47 patients who 
underwent total laryngectomy we used the Chi-Squared 
test or the Fisher Exact test, when necessary, aiming at 
identifying possible relations among variable classes and 
the groups of patients that either presented or did not 
present lapses in the area of the tracheostoma. We used 
the Mann-Whitney non-parametric test in order to com-
pare ages among the groups of patients with and without 
recurrence in the tracheostoma area.
The tests were carried out considering a 5% signi-
ficance level.
The variables analyzed were the following: age, 
gender, clinical staging (TNM), tumor location, previous/
preoperative tracheostomy, postoperative radiotherapy.
RESULTS
Recurrences in the tracheostoma area occurred 
in 5 cases (10. 6%) of 47 patients who underwent total 
laryngectomy.
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There was no statistically significant difference 
among ages (p=0.449) and gender (p<0.999) of the patients 
who had recurrences in the tracheostoma area when com-
pared to those who did not have such recurrence.
Among the 47 laryngectomized patients, according 
to the TNM-UICC classification, 14 (29.78%) patients were 
staged as T2; 23 patients (48.9%) as T3 and 10 (21.27%) 
patients were T4 (Table 1).
Of the patients who had recurrences in the tra-
cheostoma area, 2 (40%) had been staged as T2, 2 (20%) 
patients as T3; and 1 (20%) as T4. There was no statistical 
significance between tumor size (T) and recurrence in the 
tracheostoma area (p=0.864) (Table 1).
Analyzing the 47 patients with larynx epidermoid 
carcinoma who underwent total laryngectomy, 26 (55.31%) 
did not have palpable neck lymphnode at the time of di-
sease diagnosis, while 21 (44.68%) had clinically palpable 
lymphnodes and with metastatic characteristic at the time 
of disease clinical diagnosis (Table 1). There was no sta-
tistically significant correlation between neck lymphnode 
metastasis and tumor recurrence at the tracheostoma area 
(p=0.240).
The division by compromised structure showed that 
of the 5 patients with recurrence at the tracheostoma area, 
2 (40%) had initial lesion in the glottis only, 2 (40%) had 
lesion in the glottis/subglottis; and 1 (20%) had lesion in 
Table 1. Recurrence in the tracheostoma area according to clinical characteristics.
Characteristics # of patients (%) 
# of recurrences in the 
tracheostoma area  
 p
Tumor site    0,289
 glottis  18 (38,3%)  2  
 glottis/infraglottic  4 (8,5%)  2  
 supraglottis  3 (6,4%)  0  
 supraglottis/glottis  20 (42,6%)  1  
 supraglottis/glottis/infraglottic  2 (4,3%)  0  
Previous tracheostomy    0,336
 Yes  17 (36,2%)  3  
 No  30 (63,8%)  2  
N (clin)    0,240
 N0  26 (55,3%) 4  
 N1 - N3  21 (44,7%) 1  
T (clin)    0,864
 T2  14 (28,8%) 2  
 T3  23 (48,9%) 2  
 T4  10 (21,3%) 1  
Postoperative radiation    <0,999
 Yes  32 (68,1%) 4  
 No  15 (31,9%)  1  
*clin – TNM Clinical staging
the supraglottis/glottis (Table 2).
In our series there was no statistical association 
between recurrence in the tracheostoma area and the 
primary tumor affecting the subglottis (p=0.054).
We observed that of the 47 patients who underwent 
total laryngectomy, 17 (36.17%) had been submitted to 
tracheostomy prior to the definitive surgery, probably due 
to dyspnea or tumor size seen at the time of diagnosis. 
Among the 5 cases of recurrences at the tracheostoma 
area, 3 (60%) had had previous tracheostomy (Table 2). 
Even then there was no statistic significance between this 
variable and recurrences (Table 1).
Postoperative radiotherapy was used in 4 (80%) 
patients that later on evolved with recurrences at the 
tracheostoma site. In these patients, radiotherapy was 
employed because of histologically metastatic lymphnodes 
in the neck. 
We did not observe statistically significant differen-
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ces when we analyzed the recurrence in the tracheostoma 
area in relation to the use of postoperative radiotherapy 
(p<0.999).
DISCUSSION
Recurrence in the tracheostoma area is considered 
the most severe and fatal complication of laryngeal can-
cer. In the many series, the recurrence incidence in the 
tracheostoma area varies between 1.7% and 25%2,3, and in 
our study we report an incidence of 10.6%.
In 1965, Keim et al.1 revised 116 cases of patients 
who underwent total laryngectomy because of larynx 
epidermoid cancer. Recurrences in the tracheostoma area 
happened to 70 patients, all of them died. It was then 
defined that the concept of recurrence in the tracheosto-
ma area would be a diffuse neoplastic infiltration, at the 
junction between the trachea stump and the skin. Based 
on such criteria, the lesion could compromise the stomal 
epithelium, adjacent tissue or both. 
The true rates are unknown because many series 
reported in the literature classify the recurrence in the 
tracheostoma area as part of local recurrences3.
Another problem found is the large number of 
synonyms used to define this type of pathology, such as: 
tracheal metastasis, peritracheal recurrence, tracheal recur-
rence, paratracheostomal tumor persistence, tracheostomal 
metastasis, and second primary tumor in the trachea3.
Most of these recurrences are diagnosed in the first 
year after total laryngectomy12. Kowalski16 reported an 
average of 5.5 months for recurrence to appear. In his stu-
dy, 19 of 24 patients (79.2%) had recurrence after 1 year of 
follow up. Contrasting that, Modlin and Ogura11 reported 
a longer period for the recurrence diagnosis, varying from 
one to two years after laryngectomy. 
The tumor primary site is a significant risk factor 
for recurrence in the tracheostoma area. In larynx cancer, 
infraglottic involvement remains as the major risk factor for 
recurrences in the tracheostoma area 1,6,14,18. Many authors 
believe that these tumors have a tendency towards fast 
paratracheal tissue involvement, because of its submucosal 
expansion. There also is a natural trend for infraglottic 
tumors to infiltrate the larynx framework and consequen-
tly progress to invade the thyroid and perilaryngeal soft 
tissue19-22. In patients whom the infraglottic region was 
involved, the recurrence rate in the tracheostoma region 
may reach 38%6,15 and 44%7. In our study, the Infraglottic 
region involvement presented a statistical significant trend, 
and a p descriptive value of 0.054.
As far as the neck is concerned, although we have 
not seen statistically significant difference among patients 
clinically NO and N1-3 in the genesis of recurrence in 
the tracheostoma area in our study (p=0.240), we have 
to stress the importance of paratracheal lymphnodes in 
larynx cancer reported by other authors, especially when 
the tumor involves the infraglottic region4,6,13,23.
Lymphnode metastasis in head and neck tumors 
is the most important prognostic factor related to patient 
survival, especially when the primary tumor is located in 
the larynx, hypopharynx or upper esophagus. Although the 
lack of prospective studies is responsible for us not having 
enough information about the ideal surgical approach in 
the NO neck, elective neck dissection is always advocated 
when the risk of microscopic lymphnode disease in the 
neck exceeds 20%16.
In larynx tumors, especially those that affect the 
infraglottic region, the lymphnode group at risk would be 
the paratracheal and pre-tracheal lymphnode chain, and 
it is possible if these are not properly investigated and 
treated, that they would be involved in the recurrence 
we see in the tracheostoma area10,24,25. These lymphnodes 
are rarely palpable and are not routinely included in neck 
dissections. Nonetheless, considering the possibilities of 
disease dissemination towards this area, it is advisable to 
carry out neck dissection in these lymphnode chains16.
Some authors report a recurrence reduction in the 
tracheostoma area from 11.5% to 2.7% in laryngectomized 
patients in whom there was paratracheal and retrosternal 
dissection together with postoperative radiotherapy invol-
ving the upper mediastinum, tracheostoma and paratra-
cheal region.18 Paratracheal neck dissection may show up 
to 65% of microscopic lymphnode involvement in cases 
of subglottic involvement. 25.
Patients with advanced larynx tumors who present 
dyspnea at the time of diagnosis may require emergency 
tracheostomy. Many of these tumors that cause upper ai-
Table 2. Detailed information on the 5 patients with recurrences in the tracheostoma area
Patient Age  Primary site
Previous tracheos-
tomy
Postoperative radia-
tion
Staging
1 71 glottis/subglottis Yes Yes T2N0M0
2 58 supraglottis/glottis Yes Yes T2N0M0
3 76 glottis No Yes T3N1M0
4 59 glottis/subglottis Yes Yes T4N0M0
5 70 glottis No No T3N0M0
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rway obstruction also extend towards the subglottis. Prior 
tracheostomy in these patients, necessary to establish a 
new airway has been identified as an important risk factor 
for recurrences in the tracheostoma area1,7,19. This is due to 
the fact that prior tracheostomy may allow the implantation 
of viable neoplastic cells from tumor shedding that have an 
intense inflammatory process and repair granulation tissue 
- the bed may be prone to cell adhesion.2 In the literature 
such risk is reported as varying between 8 and 41%1,6.
Many authors also consent that the time span be-
tween the tracheostomy and laryngectomy could increase 
the risk of tumor implantation, thus making the surgical 
area prone to recurrences. 2,5,10.
In an attempt to establish a more adequate prog-
nosis for patients with recurrences in the tracheostoma 
area, Sisson et al.12 described a classification system for 
recurrences. Type I would be localized recurrence with a 
small nodule in the upper portion of the tracheostoma, and 
no esophageal disease. Prognosis is relatively favorable if 
the recurrence is detected at this stage. 
Type II involves the tracheostoma upper half and 
the esophagus - prognosis is variable, depending on the 
esophagus region involved. Type III starts in the tra-
cheostoma lower half, and would usually have a direct 
invasion towards the mediastinum. Type IV indicates that 
the disease extends laterally, involving the region below 
the clavicles. 
Another risk factor proposed for recurrences in the 
tracheostoma area would be endotracheal intubation as a 
source of transport and implantation of tumor cells20.
Other authors also describe recurrences in the tra-
cheostoma area in patients subjected to total laryngectomy 
that had previously undergone partial laryngectomy5,10.
It has been suggested that possible tumor cell im-
plants could occur in the tracheostoma area through the 
very contact of this area with the surgeon’s hand, that very 
likely moments before were manipulating the primary 
tumor area. We believe and agree with these authors that 
tumor implantation must not be totally disregarded as a 
possible mechanism of remote tumor spread. 
Reddy et al.21 investigated the relationship of p53 
elevation and recurrences in the tracheostoma area, when 
they studied a group of patients classified as T1 glottic. 
These patients were initially treated by radiotherapy alo-
ne and subsequently submitted to rescue laryngectomy 
because of local tumor recurrence. Recurrence in the 
tracheostoma area happened in 25% of the patients who 
underwent rescue laryngectomy after the first recurrence. 
There was no correlation between p53 elevation, obtai-
ned by means of an immunohistochemistry analysis of a 
larynx biopsy before radiotherapy and recurrence in the 
tracheostoma area. 
Identifying tumor markers related to the risk of 
distant spread, as well as chemo or radiosensibility would 
be of great help in planning therapy. Moreover, this could 
allow us to better understand the disease and then develop 
new and early methods to detect and treat this disease. 
Many prevention methods have been proposed in 
an attempt to preclude recurrences in the tracheostoma 
area, such as lower trachea resection and paratracheal 
lymphnode dissection; avoid tracheostomy prior to the 
definitive surgical procedure; emergency laryngectomy 
instead of tracheostomy in patients with severe respiratory 
obstruction; post-operative radiotherapy in the tracheos-
toma area and upper mediastinum26-29.
As we said before, prior tracheostomy is considered 
an important risk factor to the development of recurrences 
in the tracheostoma area. Aiming at avoiding this type of 
procedure, some authors have proposed emergency la-
ryngectomy in patients with severe respiratory obstruction 
due to advanced larynx tumors11,24.
Narula et al.22 described the term emergency laryn-
gectomy as being a total laryngectomy carried out within 
24 hours of the diagnosis of a malignant larynx neoplasia 
without previous treatment, because of clinical symptoms 
of respiratory obstruction presented by the patient with 
advanced stage larynx cancer. They conclude with this 
study, in which they compared two random groups (one 
group submitted to tracheostomy prior to laryngectomy 
and another group submitted to emergency laryngectomy), 
that emergency laryngectomy did not offer any advantage 
for patient survival. 
We agree with these authors, because we think the 
difficulty in performing a proper preoperative evaluation 
for such a complex procedure and the need to blindly trust 
the frozen section exam for surgery consideration would 
be factors that could discourage this type of procedure. 
Some papers state that there is a high incidence of 
thyroid gland involvement in patients with advanced stage 
larynx epidermoid cancer or with subglottis involvement. 
Based on these results, the authors advocate partial or total 
thyroidectomy in these cases13,23.
Direct thyroid gland invasion may occur in trans-
glottic tumors or supraglottis carcinomas because of tumor 
invasion through the thyroid cartilage or the cricothyroid 
membrane24,25. Indirect or secondary thyroid gland in-
volvement may also occur in subglottis or transglottic 
tumors because of lymphatic spread to the pre-laryngeal 
or Delphian node. All these examples mentioned, and 
if not considered during surgery may, with time, create 
unexpected tumor recurrence in the tracheostoma area in 
laryngectomized patients23.
Total laryngectomies are usually carried out in a bro-
ad field, including pre-laryngeal muscles and the adjacent 
soft tissue. We deem important the resection of the space 
between thyroid gland isthmus and the larynx, a place that 
may be the seat of metastasis (pre-cricothyroid nodes).
We usually do not include the thyroid gland in the 
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surgical specimen. When there is any suspicion of thyroid 
involvement, we carry out ipsilateral lobectomy on the 
lesion site or total thyroidectomy.
Better results of tumor recurrence control at the 
tracheostoma area were obtained through the association 
of post-operative radiotherapy27,30-32.
We indicate postoperative radiotherapy in cases 
where the surgical margins were compromised or very 
thin, and also in the presence of histologically confirmed 
lymphnode metastasis. In the present study, among the 5 
patients who presented recurrences in the tracheostoma 
area, 4 (80%) had undergone postoperative radiotherapy, 
including the tracheostomal field. This may cause doubts 
as to the possible usefulness of postoperative radiotherapy 
in preventing recurrences in the tracheostoma area. 
The treatment of recurrences in the tracheostoma 
area is not often curative, and palliative treatment results 
are frequently unsatisfactory1,30,33.
Since the 60’s, recurrent tumor and trachea resec-
tions associated to upper mediastinum clearance have been 
the only efficient therapeutic approaches to recurrences 
in the tracheostoma area. Many authors describe that the 
best approach for recurrences in the tracheostoma area 
is surgery2,12,28. Nonetheless, surgery must be customized 
for each patient, assessing clinical conditions in order to 
decide for such a complex procedure, and also consider 
the possible radical resection of this recurrence.
Results from radiotherapy alone are not satisfactory 
to treat recurrences in the tracheostoma area; nonetheless 
it is indicated as a palliative treatment in inoperable cases, 
both due to recurrence unresectability in the tracheostoma 
area, and unfavorable patient clinical condition 4,29,32.
Chemotherapy alone, or associated with radio-
therapy do not bring about significant responses, either 
objective or subjective, and not even enhances patient’s 
life quality for those with extensive and unresectable 
recurrencies2,16.
As we see it, surgery is the treatment of choice, 
depending on recurrence extension and the patient’s 
clinical situation. In our 5 cases, treatment employed was 
radiotherapy due to recurrence staging and the unfavorable 
clinical conditions of our patients at the time.
CONCLUSION
Recurrence in the tracheostoma area after total la-
ryngectomy still is one of the most severe and almost lethal 
complications of larynx cancer. In the present investigation, 
we did not identify factors related to the genesis of such 
recurrence based on the clinical exam of the laryngecto-
mized patients. We need further studies with more cases, 
longer follow up periods and complementary data from 
pathology in order to better understand this pathology and 
identify possible candidates for this type of recurrence and, 
thus, provide the best treatment possible for them.
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